VivoSim Labs received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement. The company has been granted an extension until September 3, 2024, to regain compliance, which could lead to delisting if not resolved.
VivoSim Labs (VVOS) has been notified by Nasdaq that it is not in compliance with the minimum bid price requirement for continued listing. This is a significant event for the company as failure to regain compliance by September 3, 2024, could result in delisting from the Nasdaq Capital Market. For traders, this presents a short-term risk of further stock price depreciation due to uncertainty and potential delisting, while long-term implications depend on the company's ability to execute a reverse stock split or other measures to increase its share price. The primary impact is on VVOS shareholders, who face increased volatility and the risk of their shares trading on less liquid markets if delisted.